- Home
- CLST vs DTIL Comparison
CLST vs DTIL Comparison
Compare CLST & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- DTIL
- Stock Information
- Founded
- CLST 1922
- DTIL 2006
- Country
- CLST United States
- DTIL United States
- Employees
- CLST N/A
- DTIL N/A
- Industry
- CLST
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- CLST
- DTIL Health Care
- Exchange
- CLST Nasdaq
- DTIL Nasdaq
- Market Cap
- CLST 52.5M
- DTIL 55.3M
- IPO Year
- CLST N/A
- DTIL 2019
- Fundamental
- Price
- CLST $13.15
- DTIL $5.03
- Analyst Decision
- CLST
- DTIL Strong Buy
- Analyst Count
- CLST 0
- DTIL 2
- Target Price
- CLST N/A
- DTIL $47.00
- AVG Volume (30 Days)
- CLST 2.7K
- DTIL 89.6K
- Earning Date
- CLST 10-23-2025
- DTIL 11-03-2025
- Dividend Yield
- CLST N/A
- DTIL N/A
- EPS Growth
- CLST N/A
- DTIL N/A
- EPS
- CLST 0.58
- DTIL N/A
- Revenue
- CLST $11,354,000.00
- DTIL $1,261,000.00
- Revenue This Year
- CLST N/A
- DTIL N/A
- Revenue Next Year
- CLST N/A
- DTIL $135.19
- P/E Ratio
- CLST $22.26
- DTIL N/A
- Revenue Growth
- CLST 164.54
- DTIL N/A
- 52 Week Low
- CLST $10.67
- DTIL $3.61
- 52 Week High
- CLST $14.23
- DTIL $11.09
- Technical
- Relative Strength Index (RSI)
- CLST 68.44
- DTIL 56.24
- Support Level
- CLST $12.66
- DTIL $4.70
- Resistance Level
- CLST $13.22
- DTIL $5.12
- Average True Range (ATR)
- CLST 0.15
- DTIL 0.26
- MACD
- CLST 0.03
- DTIL 0.02
- Stochastic Oscillator
- CLST 90.23
- DTIL 84.21
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.